• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

预测晚期上皮性卵巢癌肿瘤细胞减灭术后并发症的列线图:一项多中心回顾性队列研究

Nomogram to predict postoperative complications after cytoreductive surgery for advanced epithelial ovarian cancer: A multicenter retrospective cohort study.

作者信息

Jiang Caixia, Liu Yingwei, Tang Junying, Li Zhengyu, Min Wenjiao

机构信息

Department of Obstetrics and Gynecology, West China Second University Hospital, Sichuan University, Chengdu, China.

Department of Obstetrics and Gynecology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.

出版信息

Front Oncol. 2022 Nov 23;12:1052628. doi: 10.3389/fonc.2022.1052628. eCollection 2022.

DOI:10.3389/fonc.2022.1052628
PMID:36505869
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9728142/
Abstract

OBJECTIVE

To establish nomograms to predict the risk of postoperative complications following cytoreductive surgery in patients with advanced epithelial ovarian cancer (AEOC).

METHODS

A multicenter retrospective cohort study that included patients with FIGO stage IIIC-IV epithelial ovarian cancer who underwent cytoreductive surgery was designed. By using univariate and multivariate analyses, patient preoperative characteristics were used to predict the risk of postoperative complications. Multivariate modeling was used to develop Nomograms.

RESULTS

Overall, 585 AEOC patients were included for analysis (training cohort = 426, extrapolation cohort = 159). According to the findings, the training cohort observed an incidence of postoperative overall and severe complications of 28.87% and 6.10%, respectively. Modified frailty index (mFI) (OR 1.96 and 2.18), FIGO stage (OR 2.31 and 3.22), and Surgical Complexity Score (SCS) (OR 1.16 and 1.23) were the clinical factors that were most substantially associated to the incidence of overall and severe complications, respectively. The resulting nomograms demonstrated great internal discrimination, good consistency, and stable calibration, with C-index of 0.74 and 0.78 for overall and severe complications prediction, respectively. A satisfactory external discrimination was also indicated by the extrapolation cohort, with the C-index for predicting overall and severe complications being 0.92 and 0.91, respectively.

CONCLUSIONS

The risk of considerable postoperative morbidity exists after cytoreductive surgery for AEOC. These two nomograms with good discrimination and calibration might be useful to guide clinical decision-making and help doctors assess the probability of postoperative complications for AEOC patients.

摘要

目的

建立列线图以预测晚期上皮性卵巢癌(AEOC)患者减瘤手术后的术后并发症风险。

方法

设计了一项多中心回顾性队列研究,纳入接受减瘤手术的国际妇产科联盟(FIGO)IIIC-IV期上皮性卵巢癌患者。通过单因素和多因素分析,利用患者术前特征预测术后并发症风险。采用多因素建模开发列线图。

结果

总体而言,纳入585例AEOC患者进行分析(训练队列=426例,外推队列=159例)。根据研究结果,训练队列中术后总体并发症和严重并发症的发生率分别为28.87%和6.10%。改良虚弱指数(mFI)(比值比[OR]为1.96和2.18)、FIGO分期(OR为2.31和3.22)以及手术复杂性评分(SCS)(OR为1.16和1.23)分别是与总体并发症和严重并发症发生率最密切相关的临床因素。生成的列线图显示出良好的内部区分度、一致性和校准稳定性,总体并发症预测和严重并发症预测的C指数分别为0.74和0.78。外推队列也显示出令人满意的外部区分度,预测总体并发症和严重并发症的C指数分别为0.92和0.91。

结论

AEOC患者减瘤手术后存在相当高术后发病率的风险。这两个具有良好区分度和校准性的列线图可能有助于指导临床决策,并帮助医生评估AEOC患者术后并发症的概率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20e5/9728142/a7e43d8ddeb8/fonc-12-1052628-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20e5/9728142/7c0d724a7ee9/fonc-12-1052628-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20e5/9728142/f266fdb9609c/fonc-12-1052628-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20e5/9728142/fb94e091e53e/fonc-12-1052628-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20e5/9728142/68842a079bcb/fonc-12-1052628-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20e5/9728142/a7e43d8ddeb8/fonc-12-1052628-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20e5/9728142/7c0d724a7ee9/fonc-12-1052628-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20e5/9728142/f266fdb9609c/fonc-12-1052628-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20e5/9728142/fb94e091e53e/fonc-12-1052628-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20e5/9728142/68842a079bcb/fonc-12-1052628-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20e5/9728142/a7e43d8ddeb8/fonc-12-1052628-g005.jpg

相似文献

1
Nomogram to predict postoperative complications after cytoreductive surgery for advanced epithelial ovarian cancer: A multicenter retrospective cohort study.预测晚期上皮性卵巢癌肿瘤细胞减灭术后并发症的列线图:一项多中心回顾性队列研究
Front Oncol. 2022 Nov 23;12:1052628. doi: 10.3389/fonc.2022.1052628. eCollection 2022.
2
[Risk factor analysis on anastomotic leakage after laparoscopic surgery in rectal cancer patient with neoadjuvant therapy and establishment of a nomogram prediction model].[新辅助治疗直肠癌患者腹腔镜手术后吻合口漏的危险因素分析及列线图预测模型的建立]
Zhonghua Wei Chang Wai Ke Za Zhi. 2019 Aug 25;22(8):748-754. doi: 10.3760/cma.j.issn.1671-0274.2019.08.009.
3
Nomogram of Combining CT-Based Body Composition Analyses and Prognostic Inflammation Score: Prediction of Survival in Advanced Epithelial Ovarian Cancer Patients.基于 CT 的体成分分析与预后炎症评分联合的列线图:预测晚期上皮性卵巢癌患者的生存。
Acad Radiol. 2022 Sep;29(9):1394-1403. doi: 10.1016/j.acra.2021.11.011. Epub 2021 Dec 23.
4
[Establishment and validation of a predictive nomogram model for advanced gastric cancer with perineural invasion].[伴有神经侵犯的进展期胃癌预测列线图模型的建立与验证]
Zhonghua Wei Chang Wai Ke Za Zhi. 2020 Nov 25;23(11):1059-1066. doi: 10.3760/cma.j.cn.441530-20200103-00004.
5
Modified fragility index and surgical complexity score are able to predict postoperative morbidity and mortality after cytoreductive surgery for advanced ovarian cancer.改良的脆性指数和手术复杂度评分能够预测晚期卵巢癌细胞减灭术后的术后发病率和死亡率。
Gynecol Oncol. 2021 Apr;161(1):4-10. doi: 10.1016/j.ygyno.2020.08.022. Epub 2020 Nov 19.
6
[Establishment of a nomogram predicting risk factors of postoperative perineal wound complications after abdominoperineal resection for rectal cancer].[建立预测直肠癌腹会阴联合切除术后会阴伤口并发症危险因素的列线图]
Zhonghua Wei Chang Wai Ke Za Zhi. 2019 Apr 25;22(4):357-363. doi: 10.3760/cma.j.issn.1671-0274.2019.04.008.
7
Advanced ovarian cancer and cytoreductive surgery: Independent validation of a risk-calculator for perioperative adverse events.晚期卵巢癌和细胞减灭术:围手术期不良事件风险计算器的独立验证。
Gynecol Oncol. 2021 Feb;160(2):438-444. doi: 10.1016/j.ygyno.2020.11.021. Epub 2020 Dec 4.
8
Nomogram for 30-day morbidity after primary cytoreductive surgery for advanced stage ovarian cancer.晚期卵巢癌初次肿瘤细胞减灭术后30天发病率的列线图
Eur J Gynaecol Oncol. 2016;37(1):63-8.
9
Development and Validation of Nomograms to Predict Overall Survival Outcomes in Serous Ovarian Cancer Patients with Satisfactory Cytoreductive Surgery and Chemotherapy.预测接受满意肿瘤细胞减灭术及化疗的浆液性卵巢癌患者总生存结局列线图的开发与验证
Int J Gen Med. 2022 Jan 6;15:123-131. doi: 10.2147/IJGM.S337827. eCollection 2022.
10
Integrated prediction model of patient factors, resectability scores and surgical complexity to predict cytoreductive outcome and guide treatment plan in advanced ovarian cancer.综合预测模型的患者因素、可切除性评分和手术复杂性,以预测晚期卵巢癌的细胞减灭术效果并指导治疗计划。
Gynecol Oncol. 2022 Sep;166(3):453-459. doi: 10.1016/j.ygyno.2022.06.026. Epub 2022 Jul 9.

引用本文的文献

1
Postoperative Complications After Cytoreductive Surgery for Advanced Ovarian Carcinoma: A Single-Center Analysis Exploring the Value of the Comprehensive Complication Index and the Predictors of High Complications Burden.晚期卵巢癌肿瘤细胞减灭术后的并发症:一项探索综合并发症指数价值及高并发症负担预测因素的单中心分析
Ann Surg Oncol. 2025 Jun 24. doi: 10.1245/s10434-025-17619-9.

本文引用的文献

1
Performance validation of the Mayo triage algorithm applied to individualize surgical management of advanced epithelial ovarian cancer.梅奥分诊算法在个体化治疗晚期上皮性卵巢癌中的应用性能验证。
Gynecol Oncol. 2021 Aug;162(2):339-344. doi: 10.1016/j.ygyno.2021.06.003. Epub 2021 Jun 17.
2
Appropriate triage allows aggressive primary debulking surgery with rates of morbidity and mortality comparable to interval surgery after chemotherapy.适当的分诊可进行积极的初次肿瘤细胞减灭术,其发病率和死亡率与化疗后间隔手术相当。
Gynecol Oncol. 2021 Mar;160(3):681-687. doi: 10.1016/j.ygyno.2020.12.026. Epub 2020 Dec 31.
3
Modified fragility index and surgical complexity score are able to predict postoperative morbidity and mortality after cytoreductive surgery for advanced ovarian cancer.
改良的脆性指数和手术复杂度评分能够预测晚期卵巢癌细胞减灭术后的术后发病率和死亡率。
Gynecol Oncol. 2021 Apr;161(1):4-10. doi: 10.1016/j.ygyno.2020.08.022. Epub 2020 Nov 19.
4
Hyperthermic intraperitoneal chemotherapy in interval debulking surgery for advanced epithelial ovarian cancer: A single-center, real-life experience.腹腔内热灌注化疗在晚期上皮性卵巢癌间隔肿瘤细胞减灭术中的应用:单中心真实世界经验。
Cancer. 2020 Dec 15;126(24):5256-5262. doi: 10.1002/cncr.33167. Epub 2020 Sep 15.
5
Hyperthermic intraperitoneal chemotherapy (HIPEC) for gynecological cancer.妇科癌症的腹腔热灌注化疗(HIPEC)
J Obstet Gynaecol Res. 2020 Sep;46(9):1661-1671. doi: 10.1111/jog.14391. Epub 2020 Jul 26.
6
A multivariate analysis of the prognostic impact of tumor burden, surgical timing and complexity after complete cytoreduction for advanced ovarian cancer.晚期卵巢癌完全细胞减灭术后肿瘤负担、手术时机和复杂性的预后影响的多变量分析。
Gynecol Oncol. 2020 Sep;158(3):614-621. doi: 10.1016/j.ygyno.2020.06.495. Epub 2020 Jul 22.
7
Practical guidelines for triage to neoadjuvant chemotherapy in advanced ovarian cancer: Big risk, big reward…or too much risk?晚期卵巢癌新辅助化疗分诊实用指南:高风险,高回报……还是风险过高?
Gynecol Oncol. 2020 Jun;157(3):561-562. doi: 10.1016/j.ygyno.2020.05.003.
8
How Should we Perform a Preoperative Multidimensional Assessment of Elderly Patients with Advanced Ovarian Cancer?我们应如何对老年晚期卵巢癌患者进行术前多维度评估?
J Invest Surg. 2021 Sep;34(9):1031-1032. doi: 10.1080/08941939.2020.1761488. Epub 2020 May 7.
9
Advanced Ovarian Cancer: Weighing the Risks and Benefits of Surgery.高级卵巢癌:权衡手术的风险和获益。
Clin Obstet Gynecol. 2020 Mar;63(1):74-79. doi: 10.1097/GRF.0000000000000497.
10
A meta-analysis of morbidity and mortality in primary cytoreductive surgery compared to neoadjuvant chemotherapy in advanced ovarian malignancy.一项关于原发性细胞减灭术与新辅助化疗治疗晚期卵巢恶性肿瘤的发病率和死亡率的荟萃分析。
Gynecol Oncol. 2019 Sep;154(3):622-630. doi: 10.1016/j.ygyno.2019.07.011. Epub 2019 Jul 23.